Bridging the Drug Substance to Drug Product Continuum for Poorly Soluble Molecules

12:15 - 12:50

  • Bioavailability enhancement technology selection
  • Speed to First-in-human studies
  • Integrated drug substance and drug product services offering
  • Bioavailability enhancement case studies

David Lyon, Senior Fellow, Research, Lonza Pharma & Biotech